Category: Arthritis

The UK’s leading organisation supporting and representing the interests of people with any of the 200 forms of arthritis was last night voted Health Charity of the Year by members of the Medical Journalists’ Association. The user-led charity, which celebrated its diamond jubilee in 2007 and pre-dates the NHS by one […]

arGentis Pharmaceuticals, LLC announced that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-reviewed rheumatology research journal.

Share and Enjoy:
These icons link to social […]

Half of patients with early rheumatoid arthritis treated with the anti-tumour necrosis factor inhibitor (anti-TNF) infliximab plus methotrexate achieve remission, and up to one in five achieve drug-free remission, according to five-year follow-up results from the BeSt study. Patients treated initially with a combination of infliximab plus methotrexate achieved significantly better […]

The Arthritis Foundation announces the publication of a new book for parents of children with juvenile arthritis (JA). Released in conjunction with Juvenile Arthritis Awareness Month in July, the all-new Raising a Child with Arthritis addresses many of the concerns parents have about JA - from diagnosis and treatments […]

Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a “master switch” that helps turn on the debilitating disease. […]

People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases.

Share and Enjoy:
These icons […]

UCB announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of Cimzia® (certolizumab pegol) as a subcutaneous treatment for adults with moderate to severe active rheumatoid arthritis (RA) and has been accepted for review. Subject to approval, Cimzia® will be the first and only PEGylated, […]

Roche has announced the results of a pilot study evaluating the use of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting the risk of cardiovascular adverse events (CV-AE) in patients treated with non-steroidal anti-inflammatory drugs of the COX inhibitor class. Non-steroidal anti-inflammatory drugs (NSAIDs) - for example, acetylsalicylic acid and ibuprofen - are […]

A new study published in the Annals of the Rheumatic Diseases finds that compared to females born with average birth weight, those born with heavy birth weight are two times as likely to develop rheumatoid arthritis when they become adults. Rheumatoid arthritis is a condition that occurs when the immune system […]

Centocor, Inc. announced that a Biologics License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of golimumab (CNTO 148) as a monthly subcutaneous treatment for adults with active forms of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Share and […]